title: Intensive chemotherapy for acute lymphoblastic leukaemia in adults.
authors.affiliation: CRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK.
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: R
authors.initials: R
authors.lastname: Bassan
authors.forename: R
authors.initials: R
authors.lastname: Battista
authors.forename: M J
authors.initials: MJ
authors.lastname: Barnett
authors.forename: W
authors.initials: W
authors.lastname: Gregory
authors.forename: J
authors.initials: J
authors.lastname: Lim
authors.forename: J
authors.initials: J
authors.lastname: Amess
authors.forename: A
authors.initials: A
authors.lastname: Oza
authors.forename: T
authors.initials: T
authors.lastname: Barbui
authors.forename: M
authors.initials: M
authors.lastname: Horton
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007558:Italy / Q000453:epidemiology; D015993:Life Tables; D015337:Multicenter Studies as Topic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D011239:Prednisolone / Q000008:administration & dosage; D012074:Remission Induction; D015996:Survival Rate; D006113:United Kingdom / Q000453:epidemiology; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D001215:Asparaginase